
Effects of particle size, food, and capsule shell composition on the oral bioavailability of dabrafenib, a BRAF inhibitor, in patients with BRAF mutation-positive tumors
Keywords: فراهم زیستی; dabrafenib; food effects; particle size; bioavailability; HPMC; gelatin; capsules; supersaturation; dissolution; clinical pharmacokinetics